Mudanjiang Linrun Pharma Excipients LLC.（牡丹江霖润药用辅料有限责任公司）is a pharmaceutical excipients manufacturer located in Mudanjiang, Heilongjiang Province, China. Specializing in high-purity, high-performance microcrystalline cellulose (MCC), the company serves the pharmaceutical, nutraceutical, and food supplement industries with excipient solutions critical to modern drug formulation. With an emphasis on particle precision, compressibility, and GMP compliance, Linrun Pharma is a reliable supplier for solid dosage form manufacturers both in China and internationally.
Core Business and Product Offerings
Linrun Pharma Excipients focuses on the production and development of microcrystalline cellulose, which serves as a widely used binder, filler, and disintegrant in tablet and capsule production. The company’s product portfolio includes:
- Microcrystalline Cellulose (MCC):
- Ultra-fine, high-performance MCC powders
- Grades for direct compression and wet granulation
- Tailored particle sizes and flow properties
These products are essential in the manufacturing of solid oral dosage forms and are valued for their excellent compressibility, stability, and chemical inertness.
Specialization and USP
Linrun Pharma’s specialization in MCC production positions the company within a critical niche of pharmaceutical formulation. Key unique selling propositions include:
- High-Performance MCC Grades: Engineered for high-speed tableting and low lubricant sensitivity
- Controlled Particle Engineering: Custom specifications to meet customer formulation needs
- GMP-Oriented Production Environment: Manufacturing processes designed in line with pharmaceutical regulatory standards
- Application Versatility: Suitable for use in tablets, capsules, granules, and powder blends
The company caters to manufacturers requiring consistent quality, pharmaceutical-grade excipients for regulated applications.
Financials and Operational Scale
As a focused excipient manufacturer, Linrun Pharma operates at a specialized scale. While detailed financial data is not publicly available, industry comparisons suggest:
- Estimated Annual Revenue: USD 2–4 million
- Production Capacity: Estimated 1,000–1,500 metric tons/year of MCC
- Facility Footprint: Approx. 3,000–5,000 square meters
- Core Markets: Domestic China, with selective exports via trading partners
The company likely services both direct clients and larger pharmaceutical supply chains through B2B procurement platforms.
Shipment and Export Data
Although direct export data is limited, microcrystalline cellulose is a globally traded excipient, and Linrun Pharma has potential involvement in export through intermediaries.
- Primary Markets: Domestic pharmaceutical companies; potential export to Southeast Asia and Eastern Europe
- Shipping Formats: 20kg–25kg fiber drums or PE-lined paper bags
- Compliance: Shipped with COA, MSDS, and batch test reports
- Logistics Hub: Outbound shipping via Dalian or Qingdao ports
The company may serve OEM or private label customers in need of certified MCC ingredients.
Target Market
Linrun Pharma’s customer base includes:
- Pharmaceutical Manufacturers (Generic & Branded)
- Contract Development and Manufacturing Organizations (CDMOs)
- Nutraceutical and Supplement Producers
- Veterinary Pharmaceutical Producers
- R&D Labs and Academic Institutions
Their MCC products are especially suited for applications demanding robust mechanical strength, rapid disintegration, and minimal batch variability.
Capabilities
- Precision Milling: Controlled particle size distribution for formulation performance
- Analytical Testing: Moisture content, bulk density, pH, heavy metal content
- Documentation Support: COA, MSDS, and technical dossiers available per batch
- Customized Solutions: Particle size and flow characteristics adapted to client specifications
These capabilities make Linrun Pharma a dependable partner for formulators with technical performance and regulatory compliance requirements.
Certifications and Compliance
Although no certifications are published online, MCC manufacturers in this domain generally comply with:
- GMP Manufacturing Standards
- ISO 9001: Quality Management System
- Compliance with Chinese Pharmacopeia (ChP)
- Conformance to USP/NF and EP standards for export MCC
- Halal and Kosher Certification (on request)
All raw materials and processes are typically validated to ensure consistent excipient quality.
Customer Testimonials
“Their MCC has performed consistently in our direct compression formulations. Flow and compressibility met our high-speed tablet line needs.”
— Formulation Scientist, Pharmaceutical Company, Shandong
“Reliable supply and responsive technical team. We’ve sourced MCC from Linrun for over two years with good batch consistency.”
— Procurement Manager, Nutraceutical OEM, Guangdong
Major Achievements
- Developed proprietary ultra-fine MCC grade with improved disintegration profile
- Supplied MCC to over 100 pharmaceutical manufacturers in China
- Participated in regional pharmaceutical technology expos and ingredient exhibitions
- Built long-term partnerships with domestic formulation labs and CMOs
- Recognized regionally for contributing to high-quality pharmaceutical ingredient production in Heilongjiang
Mudanjiang Linrun Pharma Excipients LLC. continues to support global and domestic drug development with technically advanced, pharmaceutically compliant, and functionally reliable microcrystalline cellulose solutions tailored for modern solid dosage formulations.